| NAME | : | Ertugliflozin |
| BOBOT | : | 436.89 |
| RUMUS | : | C22H25ClO7 |
| THERAPEUTIC INDC | : | Ertugliflozin as a monotherapy is indicated to improve the glycemic control in adult patients with type 2 diabetes.[FDA label] Ertugliflozin, in co... |
| CATEGORIES | : | BCRP/ABCG2 Substrates / Diuretics / P-glycoprotein/ABCB1 Substrates / Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / UGT1A1 Inhibitors |
| STRUCTURE | : |  |